Table 3 Adverse reactions to postoperative adjuvant chemotherapy in both groups of patients
Toxic reaction | Grade 1–2 | P | Grade 3–4 | P | ||
|---|---|---|---|---|---|---|
CAPE-OX-CRT group (%) | Control group (%) | CAPE-OX-CRT group (%) | Control group (%) | |||
Diarrhea | 10/30 (33.33%) | 7/26 (26.92%) | 0.602 | 5/30 (16.67%) | 3/26 (11.54%) | 0.712 |
Bone-marrow suppression | 22/30 (73.33%) | 10/26 (38.46%) | 0.008 | 4/30 (13.33%) | 2/26 (7.69%) | 0.675 |
Nausea/vomiting | 17/30 (56.67%) | 10/26 (38.46%) | 0.173 | 7/30 (23.33%) | 3/26 (11.54%) | 0.310 |
Liver dysfunction | 4//30 (13.33%) | 2/26 (7.69%) | 0.303 | 0 | 0 | – |
Fatigue | 20/30 (66.67%) | 12/26 (46.15%) | 0.121 | 6/30 (20%) | 2/22 (7.69%) | 0.263 |
Peripheral neurotoxic reactions | 8/30 (26.67%) | 4/26 (15.38%) | 0.528 | 0 | 0 | – |